Inactive Instrument

All News Nexvet Biopharma public limited Co

Equities

End-of-day quote Nasdaq Other stock markets
-	-

Nexvet Biopharma plc ("Nexvet") Rule 17(d) Announcement	17-07-28	GL
Nexvet Biopharma plc ("Nexvet") Rule 17(c) Announcement	17-07-10	GL
Nexvet Biopharma plc ("Nexvet") Rule 2.10 Announcement	17-07-05	GL
Nexvet Biopharma plc ("Nexvet") Supplement Announcement	17-07-03	GL
Nexvet Biopharma plc ("Nexvet") Rule 2.10 Announcement	17-06-19	GL
Nexvet Biopharma plc ("Nexvet") Rule 15 Announcement	17-06-16	GL
Nexvet Biopharma plc ("Nexvet") Rule 2.10 Announcement	17-06-14	GL
Nexvet Biopharma plc ("Nexvet") Rule 17(b) Announcement	17-06-07	GL
Nexvet Biopharma : Definitive Proxy Statement	17-06-05	PU
Nexvet Biopharma : Rule 17 Announcement	17-06-05	PU
Nexvet Biopharma plc ("Nexvet") Rule 17 Announcement	17-06-02	GL
Nexvet Biopharma plc ("Nexvet") Rule 2.10 Announcement	17-06-01	GL
Nexvet Biopharma plc ("Nexvet") Rule 2.10 Announcement	17-05-11	GL
Nexvet Reports Financial Results for Third Quarter of Fiscal Year 2017	17-05-11	GL
Nexvet to Present at the Cowen and Company 37th Annual Health Care Conference	17-02-22	GL
Nexvet Reports Financial Results for Second Quarter of Fiscal Year 2017	17-02-10	GL
Nexvet Announces Initiation of Pivotal Efficacy Study of Frunevetmab in Cats	16-12-12	GL
Nexvet Reports Financial Results for First Quarter of Fiscal Year 2017	16-11-04	GL
Nexvet to Present at the 25th Annual Credit Suisse Healthcare Conference	16-10-19	GL
Nexvet Biopharma Reports Full Year Fiscal 2016 Results	16-09-02	GL

No results for this search